CalciMedica announces 1-for-5 reverse stock split, authorized shares cut to 100M

CalciMedica, Inc.

Reverse split effective 5:00 p.m. ET Aug 28, 2026; trading on split-adjusted basis Aug 31, 2026 under CALC.
Authorized common shares reduced from 500M to 100M; par value unchanged at $0.0001.
No fractional shares; cash payment in lieu; options, RSUs, warrants proportionately adjusted.
New CUSIP 38942Q301; stockholder approval at Aug 19, 2026 annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.